Jane Street Group LLC lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 18.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 25,556 shares of the company’s stock after buying an additional 3,932 shares during the quarter. Jane Street Group LLC’s holdings in Henry Schein were worth $1,768,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. Venturi Wealth Management LLC raised its holdings in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the period. Quent Capital LLC raised its holdings in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the period. Smartleaf Asset Management LLC raised its holdings in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the period. Allworth Financial LP raised its holdings in shares of Henry Schein by 180.7% during the 4th quarter. Allworth Financial LP now owns 946 shares of the company’s stock valued at $71,000 after buying an additional 609 shares during the period. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in shares of Henry Schein during the 4th quarter valued at about $95,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Henry Schein
In related news, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on HSIC
Henry Schein Price Performance
Shares of NASDAQ HSIC opened at $72.05 on Friday. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.77 billion, a price-to-earnings ratio of 29.65, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The business has a 50 day simple moving average of $67.34 and a 200-day simple moving average of $71.46.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.10 EPS. The business’s quarterly revenue was down .1% on a year-over-year basis. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- How to Profit From Growth Investing
- Top 4 ETFs for China Exposure After Tariff Relief
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Build a Complete Bond Portfolio With These 4 ETFs
- What is the FTSE 100 index?
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.